172 related articles for article (PubMed ID: 36564648)
1. Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader-Willi syndrome.
Cheng RQ; Ying YQ; Qiu ZQ; Fu JF; Gong CX; Yang YL; Shi W; Li H; Ma MS; Wang CY; Liu M; Chen JJ; Su C; Luo XP; Luo FH; Lu W
World J Pediatr; 2023 May; 19(5):438-449. PubMed ID: 36564648
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
Yang A; Choi JH; Sohn YB; Eom Y; Lee J; Yoo HW; Jin DK
Orphanet J Rare Dis; 2019 Sep; 14(1):216. PubMed ID: 31511031
[TBL] [Abstract][Full Text] [Related]
3. EFFECT OF GROWTH HORMONE THERAPY IN CHILDREN WITH PRADER-WILLI SYNDROME - OUR FIRST EXPERIENCES.
Stipančić G; Požgaj Šepec M; La Grasta Sabolić L
Acta Clin Croat; 2018 Dec; 57(4):744-755. PubMed ID: 31168212
[TBL] [Abstract][Full Text] [Related]
4. Effects of early recombinant human growth hormone treatment in young Chinese children with Prader-Willi syndrome.
Gao Y; Yang LL; Dai YL; Shen Z; Zhou Q; Zou CC
Orphanet J Rare Dis; 2023 Feb; 18(1):25. PubMed ID: 36750945
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
[TBL] [Abstract][Full Text] [Related]
6. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
7. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.
Scheermeyer E; Harris M; Hughes I; Crock PA; Ambler G; Verge CF; Bergman P; Werther G; Craig ME; Choong CS; Davies PSW;
Growth Horm IGF Res; 2017 Jun; 34():1-7. PubMed ID: 28427039
[TBL] [Abstract][Full Text] [Related]
8. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
[TBL] [Abstract][Full Text] [Related]
9. Early psychomotor development and growth hormone therapy in children with Prader-Willi syndrome: a review.
Jin YY; Luo FH
Eur J Pediatr; 2024 Mar; 183(3):1021-1036. PubMed ID: 37987848
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months.
Whitman B; Carrel A; Bekx T; Weber C; Allen D; Myers S
J Pediatr Endocrinol Metab; 2004 Apr; 17(4):591-600. PubMed ID: 15198290
[TBL] [Abstract][Full Text] [Related]
11. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
[TBL] [Abstract][Full Text] [Related]
12. Safety and effectiveness of growth hormone therapy in infants with Prader-Willi syndrome younger than 2 years: a prospective study.
Corripio R; Tubau C; Calvo L; Brun C; Capdevila N; Larramona H; Gabau E
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):879-884. PubMed ID: 31271556
[TBL] [Abstract][Full Text] [Related]
13. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits.
Myers SE; Whitman BY; Carrel AL; Moerchen V; Bekx MT; Allen DB
Am J Med Genet A; 2007 Mar; 143A(5):443-8. PubMed ID: 17103437
[TBL] [Abstract][Full Text] [Related]
14. Short-term effects of growth hormone treatment on the upper airways of non severely obese children with Prader-Willi syndrome.
Salvatoni A; Veronelli E; Nosetti L; Berini J; de Simone S; Iughetti L; Bosio L; Chiumello G; Grugni G; Delù G; Castelnuovo P; Trifirò G; Nespoli L
J Endocrinol Invest; 2009 Jul; 32(7):601-5. PubMed ID: 19498323
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the effect of recombinant human growth hormone treatment on sleep-related breathing disorders in toddlers with Prader-Willi syndrome: a one-year retrospective cohort study.
Guo H; Fu J; Zhou Y; Luo F; Cheng R
BMC Pediatr; 2024 Jan; 24(1):32. PubMed ID: 38200464
[TBL] [Abstract][Full Text] [Related]
16. [Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy].
Lämmer C; Weimann E
Wien Med Wochenschr; 2007 Feb; 157(3-4):82-8. PubMed ID: 17340066
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
[TBL] [Abstract][Full Text] [Related]
18. Effects of growth hormone treatment on height, weight, and obesity in Taiwanese patients with Prader-Willi syndrome.
Lin HY; Lin SP; Tsai LP; Chao MC; Chen MR; Chuang CK; Huang CY; Tsai FJ; Chou IC; Chiu PC; Huang CH; Yen JL; Lin JL; Kuo PL
J Chin Med Assoc; 2008 Jun; 71(6):305-9. PubMed ID: 18567561
[TBL] [Abstract][Full Text] [Related]
19. Five years of growth hormone treatment in children with Prader-Willi syndrome. Swedish National Growth Hormone Advisory Group.
Lindgren AC; Ritzén EM
Acta Paediatr Suppl; 1999 Dec; 88(433):109-11. PubMed ID: 10626558
[TBL] [Abstract][Full Text] [Related]
20. Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome.
Carrel AL; Myers SE; Whitman BY; Eickhoff J; Allen DB
J Clin Endocrinol Metab; 2010 Mar; 95(3):1131-6. PubMed ID: 20061431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
